AI assistant
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015
Nov 19, 2015
33148_dirs_2015-11-18_363d0806-63fd-47aa-aa9f-c5f0ff78574b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-11-16
Reporting Person: Rho Ventures IV Holdings LLC (10% Owner)
Reporting Person: Rho Ventures IV-A, L.P. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-16 | Common Stock | J | 115083 | — | Disposed | 636496 | Direct |
| 2015-11-16 | Common Stock | J | 127711 | — | Disposed | 0 | Direct |
Footnotes
F1: On November 16, 2015, Rho Ventures IV Holdings LLC ("RV IV Holdings") distributed, for no consideration, 115,083 shares of Common Stock of the Issuer to one or more of its members. The distribution was made in accordance with the exemption afforded by Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
F2: Shares are held by RV IV Holdings
F3: On November 16, 2015, Rho Ventures IV-A, L.P. ("RV IV-A") distributed, for no consideration, 127,711 shares of Common Stock of the Issuer to one or more of its partners. The distribution was made in accordance with the exemption afforded by Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
F4: RV IV-A no longer holds any shares of the Issuer.